Safety and Benefits of Contraceptives Implants: A Systematic Review
- PMID: 34201123
- PMCID: PMC8229462
- DOI: 10.3390/ph14060548
Safety and Benefits of Contraceptives Implants: A Systematic Review
Abstract
Progestin-only contraceptive implants provide long-acting, highly effective reversible contraception. We searched the medical publications in PubMed, CENTRAL, and EMBASE for relevant articles on hormonal implants published in English between 1990 and 2021. Levonorgestrel (LNG) 6-capsule subdermal implants represented the first effective system approved for reversible contraception. The etonogestrel (ENG) single rod dispositive has been widely employed in clinical practice, since it is a highly effective and safe contraceptive method. Abnormal menstrual bleeding is a common ENG side effect, representing the main reason for its premature discontinuation. Emerging evidence demonstrated that it is possible to extend the use of the ENG implant beyond the three-year period for which it is approved. The ENG implant could be an effective and discrete alternative to the IUD in young girls, such as post-partum/post-abortion. Implants should be inserted by trained skilled clinicians who previously provide adequate counselling about their contraceptive effect, benefits, and any possible adverse events. More studies are needed to validate the extended use of the ENG implant for up to 5 years.
Keywords: LARC; contraception; etonogestrel; implanon; levonorgestrel; nexplanon; subdermal implant.
Conflict of interest statement
The authors certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript.
Similar articles
-
Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.Hum Reprod. 2016 Nov;31(11):2491-2498. doi: 10.1093/humrep/dew222. Epub 2016 Sep 26. Hum Reprod. 2016. PMID: 27671673 Free PMC article. Clinical Trial.
-
A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.Hum Reprod. 2014 Jul;29(7):1393-9. doi: 10.1093/humrep/deu089. Epub 2014 May 8. Hum Reprod. 2014. PMID: 24812309 Clinical Trial.
-
Subdermal contraceptive implants.J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):223-6. doi: 10.1016/0960-0760(95)00051-z. J Steroid Biochem Mol Biol. 1995. PMID: 7626459 Review.
-
Changes in body composition in women using long-acting reversible contraception.Contraception. 2017 Apr;95(4):382-389. doi: 10.1016/j.contraception.2016.12.006. Epub 2016 Dec 30. Contraception. 2017. PMID: 28041992 Free PMC article.
-
Canadian Contraception Consensus (Part 1 of 4).J Obstet Gynaecol Can. 2015 Oct;37(10):936-42. doi: 10.1016/s1701-2163(16)30033-0. J Obstet Gynaecol Can. 2015. PMID: 26606712 English, French.
Cited by
-
Removal of 2-Rod Subdermal Implant Identified on X-Ray: A Case Report.Clin Case Rep. 2025 Aug 7;13(8):e70737. doi: 10.1002/ccr3.70737. eCollection 2025 Aug. Clin Case Rep. 2025. PMID: 40787161 Free PMC article.
-
Injectable long acting antiretroviral for HIV treatment and prevention: perspectives of potential users.BMC Infect Dis. 2023 Feb 17;23(1):98. doi: 10.1186/s12879-023-08071-9. BMC Infect Dis. 2023. PMID: 36803606 Free PMC article.
-
Safety and efficacy of a biodegradable implant releasing tenofovir alafenamide for vaginal protection in a macaque model.J Antimicrob Chemother. 2022 Oct 28;77(11):2964-2971. doi: 10.1093/jac/dkac252. J Antimicrob Chemother. 2022. PMID: 35913838 Free PMC article.
-
Clinical efficacy of etonogestrel implants on relieving dysmenorrhea in endometriosis and adenomyosis women for up to 3 years.Front Med (Lausanne). 2025 Mar 21;12:1460578. doi: 10.3389/fmed.2025.1460578. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40190575 Free PMC article.
-
Infective Endocarditis in Hypertrophic Obstructive Cardiomyopathy After Etonogestrel Implant Removal.Cureus. 2022 Oct 1;14(10):e29810. doi: 10.7759/cureus.29810. eCollection 2022 Oct. Cureus. 2022. PMID: 36337782 Free PMC article.
References
-
- Hubacher D., Spector H., Monteith C., Chen P.L., Hart C. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: A randomized patient preference trial. Am. J. Obstet. Gynecol. 2017;216:101–109. doi: 10.1016/j.ajog.2016.08.033. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources